MyFinsight
Home
Blog
About
Short-term investments
$314,894K
(343.69%↑ Y/Y)
Cash and cash
equivalents
$85,382K
(101.90%↑ Y/Y)
Prepaid expenses and
other current assets
$7,607K
(299.74%↑ Y/Y)
Restricted cash, current
portion
$49K
(145.00%↑ Y/Y)
Total current assets
$407,932K
(254.15%↑ Y/Y)
Long-term investments
$71,878K
Goodwill
$10,502K
(0.00%↑ Y/Y)
Property and equipment,
net
$288K
(-58.02%↓ Y/Y)
Restricted cash, net of
current portion
$183K
(-12.86%↓ Y/Y)
Total assets
$490,783K
(287.72%↑ Y/Y)
Total liabilities,
mezzanine equity and...
$490,783K
(287.72%↑ Y/Y)
Total stockholders
equity
$448,660K
(329.04%↑ Y/Y)
Total liabilities
$42,123K
(91.39%↑ Y/Y)
Accumulated deficit
-$504,510K
(-24.82%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$583K
(-1614.71%↓ Y/Y)
Additional paid-in capital
$953,700K
(87.45%↑ Y/Y)
Total current
liabilities
$21,130K
(128.21%↑ Y/Y)
Derivative liability,
non-current
$18,530K
(80.60%↑ Y/Y)
Royalty obligation
$2,000K
(0.00%↑ Y/Y)
Deferred tax liability,
net
$463K
(58.02%↑ Y/Y)
Common stock0.001 par
value 200,000,000...
$53K
(381.82%↑ Y/Y)
Accrued expenses and
other current...
$17,783K
(172.62%↑ Y/Y)
Accounts payable
$3,347K
(41.46%↑ Y/Y)
Back
Back
Balance Sheet
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)
source: myfinsight.com